|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.35/-0.42
|
企業價值
80.28M
|
資產負債 |
每股賬面淨值
-0.03
|
現金流量 |
現金流量率
--
|
損益表 |
收益
0
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/24 13:03 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significantneed for new treatments in cancers of the bone in children and young adults. |